From October 1, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 400,000 shares, representing 0.51% for CNY 22.64 million under the buyback announced on August 17, 2023.
Hangzhou Alltest Biotech Co., Ltd.
Equities
688606
CNE1000053G6
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51.72 CNY | -2.12% |
|
-0.08% | -24.61% |
04-29 | China, HK stocks rise, led by property shares | RE |
04-26 | Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-24.61% | 553M | |
-10.34% | 11.48B | |
-9.80% | 7.64B | |
+27.84% | 5.49B | |
-15.47% | 3.86B | |
+8.47% | 2.61B | |
-63.81% | 2.42B | |
-10.68% | 2.27B | |
+21.21% | 2.1B | |
-9.38% | 1.76B |
- Stock Market
- Equities
- 688606 Stock
- News Hangzhou Alltest Biotech Co., Ltd.
- Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023.